Mural Oncology PLC Logo

Mural Oncology PLC

Clinical-stage company developing cytokine immunotherapies for hard-to-treat solid tumors.

MURA | BUD

Overview

Corporate Details

ISIN(s):
IE000LK2BOB4
LEI:
Country:
Ireland
Address:
N/A
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Mural Oncology PLC is a clinical-stage oncology company focused on developing novel immunotherapies to treat cancer. The company leverages its proprietary protein engineering platform and expertise in cytokine biology to design and advance a pipeline of cytokine-based therapies. Its mission is to unlock the value of immunotherapy for a broader range of patients, particularly those with cancers that have not responded to previous treatments. The company's lead candidate, nemvaleukin alfa, is a novel, engineered interleukin-2 (IL-2) variant immunotherapy currently in clinical trials for difficult-to-treat solid tumors, including advanced melanoma and platinum-resistant ovarian cancer.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-24 22:25
Post-Annual General Meeting Information
Mural Oncology Announces that Mural Shareholders Approve the Proposed Acquisiti…
English 31.3 KB
2025-09-24 01:52
Proxy Solicitation & Information Statement
Mural Oncology Announces Commencement of Mailing of Definitive Proxy Statement …
English 18.3 KB

Automate Your Workflow. Get a real-time feed of all Mural Oncology PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Mural Oncology PLC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Mural Oncology PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

B2B platform for Ukraine-Korea trade, investment, and post-war reconstruction.
South Korea
052770
IVISIONWORKS CO.,LTD. Logo
Accelerates social impact startups & develops digital therapeutics for cognitive rehabilitation.
South Korea
469750
A diversified, Asia-focused conglomerate with businesses in property, retail, auto, and more.
Bermuda
JARD
The world's largest uranium producer, managing the front-end of the global nuclear fuel cycle.
Kazakhstan
KZAP
KAINOS MEDICINE, INC. Logo
Develops small molecule drugs for neurodegenerative diseases, cancers, and infectious diseases.
South Korea
284620
Kanamoto Co., Ltd. Logo
Global provider of rental construction equipment, also selling used machinery and steel products.
Japan
9678
Keihan Holdings Co.,Ltd. Logo
A conglomerate integrating transport, real estate, and retail for regional development.
Japan
9045
Kezar Life Sciences, Inc. Logo
Developing novel small molecule therapies for immune-mediated diseases and oncology.
United States of America
KZR
KNT-CT Holdings Co.,Ltd. Logo
A travel holding company offering themed tours and corporate travel solutions to boost Japan tourism.
Japan
9726
KoBioLabs, Inc. Logo
Develops AI-driven microbiome therapeutics for immune, metabolic, and brain disorders.
South Korea
348150

Talk to a Data Expert

Have a question? We'll get back to you promptly.